A detailed history of Aqr Capital Management LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Aqr Capital Management LLC holds 73,601 shares of RDY stock, worth $1.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
73,601
Previous 91,186 19.28%
Holding current value
$1.06 Million
Previous $6.95 Million 15.83%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$75.41 - $84.21 $1.33 Million - $1.48 Million
-17,585 Reduced 19.28%
73,601 $5.85 Million
Q2 2024

Aug 14, 2024

SELL
$68.26 - $76.19 $518,639 - $578,891
-7,598 Reduced 7.69%
91,186 $6.95 Million
Q1 2024

May 15, 2024

BUY
$67.36 - $77.59 $928,557 - $1.07 Million
13,785 Added 16.22%
98,784 $7.25 Million
Q4 2023

Feb 14, 2024

SELL
$64.27 - $69.9 $869,187 - $945,327
-13,524 Reduced 13.73%
84,999 $5.91 Million
Q3 2023

Nov 14, 2023

BUY
$61.9 - $72.77 $192,632 - $226,460
3,112 Added 3.26%
98,523 $6.59 Million
Q2 2023

Aug 14, 2023

BUY
$53.34 - $63.11 $1.19 Million - $1.41 Million
22,310 Added 30.52%
95,411 $6.02 Million
Q1 2023

May 15, 2023

SELL
$51.63 - $56.93 $1.75 Million - $1.93 Million
-33,873 Reduced 31.66%
73,101 $4.16 Million
Q4 2022

Feb 14, 2023

SELL
$51.15 - $57.45 $417,332 - $468,734
-8,159 Reduced 7.09%
106,974 $5.54 Million
Q3 2022

Nov 14, 2022

SELL
$49.9 - $57.32 $219,310 - $251,921
-4,395 Reduced 3.68%
115,133 $6.03 Million
Q2 2022

Aug 15, 2022

SELL
$49.62 - $58.13 $920,252 - $1.08 Million
-18,546 Reduced 13.43%
119,528 $6.62 Million
Q1 2022

May 16, 2022

SELL
$48.27 - $65.25 $873,107 - $1.18 Million
-18,088 Reduced 11.58%
138,074 $7.7 Million
Q4 2021

Feb 14, 2022

SELL
$59.5 - $67.25 $2.61 Million - $2.95 Million
-43,832 Reduced 21.92%
156,162 $10.2 Million
Q3 2021

Nov 15, 2021

BUY
$60.19 - $75.29 $1.21 Million - $1.51 Million
20,080 Added 11.16%
199,994 $13 Million
Q2 2021

Aug 16, 2021

SELL
$62.12 - $74.2 $625,921 - $747,639
-10,076 Reduced 5.3%
179,914 $13.2 Million
Q1 2021

May 17, 2021

BUY
$57.98 - $73.08 $980,905 - $1.24 Million
16,918 Added 9.78%
189,990 $11.7 Million
Q4 2020

Feb 16, 2021

SELL
$62.61 - $71.29 $685,579 - $780,625
-10,950 Reduced 5.95%
173,072 $12.3 Million
Q3 2020

Nov 16, 2020

SELL
$51.39 - $72.41 $674,493 - $950,381
-13,125 Reduced 6.66%
184,022 $12.8 Million
Q2 2020

Aug 17, 2020

SELL
$39.55 - $54.65 $3.18 Million - $4.39 Million
-80,373 Reduced 28.96%
197,147 $10.5 Million
Q1 2020

May 15, 2020

SELL
$34.75 - $45.85 $1.76 Million - $2.33 Million
-50,776 Reduced 15.47%
277,520 $11.2 Million
Q4 2019

Feb 14, 2020

BUY
$36.66 - $41.78 $435,154 - $495,928
11,870 Added 3.75%
328,296 $13.3 Million
Q3 2019

Nov 14, 2019

SELL
$34.82 - $39.26 $1.84 Million - $2.08 Million
-52,964 Reduced 14.34%
316,426 $12 Million
Q2 2019

Aug 14, 2019

SELL
$36.05 - $42.76 $4.83 Million - $5.72 Million
-133,886 Reduced 26.6%
369,390 $13.8 Million
Q1 2019

May 14, 2019

SELL
$35.77 - $40.57 $1.52 Million - $1.72 Million
-42,458 Reduced 7.78%
503,276 $20.4 Million
Q4 2018

Feb 14, 2019

BUY
$31.89 - $38.44 $424,838 - $512,097
13,322 Added 2.5%
545,734 $20.6 Million
Q3 2018

Nov 15, 2018

SELL
$29.25 - $36.73 $17,403 - $21,854
-595 Reduced 0.11%
532,412 $18.4 Million
Q2 2018

Aug 14, 2018

SELL
$28.49 - $35.06 $53,789 - $66,193
-1,888 Reduced 0.35%
533,007 $17.2 Million
Q1 2018

May 15, 2018

SELL
$31.93 - $39.54 $3.04 Million - $3.76 Million
-95,210 Reduced 15.11%
534,895 $17.5 Million
Q4 2017

Feb 14, 2018

SELL
$34.15 - $37.62 $8.96 Million - $9.88 Million
-262,513 Reduced 29.41%
630,105 $23.7 Million
Q3 2017

Nov 14, 2017

BUY
$30.11 - $37.72 $26.9 Million - $33.7 Million
892,618
892,618 $31.8 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.4B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.